Cholestyramine as monotherapy for Graves' hyperthyroidism.
作者信息
Er Chaozer, Sule Ashish Anil
机构信息
Department of General Medicine, Tan Tock Seng Hospital, Singapore.
出版信息
Singapore Med J. 2016 Nov;57(11):644-645. doi: 10.11622/smedj.2016177.
Abstract
摘要
相似文献
1
Cholestyramine as monotherapy for Graves' hyperthyroidism.
Singapore Med J. 2016 Nov;57(11):644-645. doi: 10.11622/smedj.2016177.
2
The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Clin Endocrinol (Oxf). 2005 May;62(5):521-4. doi: 10.1111/j.1365-2265.2005.02249.x.
3
Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
N Engl J Med. 1996 Jan 25;334(4):220-4. doi: 10.1056/NEJM199601253340403.
4
Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
Thyroid. 1999 Dec;9(12):1181-8. doi: 10.1089/thy.1999.9.1181.
5
Successful management of Graves' disease in a patient undergoing regular dialysis therapy.
Arch Intern Med. 1985 Feb;145(2):337-9.
6
Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
QJM. 1995 Mar;88(3):175-80.
7
Low doses of cholestyramine in the treatment of hyperthyroidism.
Endocrine. 2008 Aug-Dec;34(1-3):52-5. doi: 10.1007/s12020-008-9107-5. Epub 2008 Oct 23.
8
Sequential assessment during drug treatment of thyrotoxicosis.
Clin Endocrinol (Oxf). 1973 Jan;2(1):43-50. doi: 10.1111/j.1365-2265.1973.tb03483.x.
9
Development of Graves' disease after long-standing hypothyroidism on treatment, with acute toxicity to thionamides and lithium.
BMJ Case Rep. 2012 Aug 1;2012:bcr2012006433. doi: 10.1136/bcr-2012-006433.
10
Carbimazole and the autoimmune response in Graves' disease.
N Engl J Med. 1980 Aug 7;303(6):302-7. doi: 10.1056/NEJM198008073030603.
引用本文的文献
1
Antithyroid Drugs in the Management of Graves' Disease: A Friend and Foe.
Cureus. 2023 Mar 11;15(3):e36028. doi: 10.7759/cureus.36028. eCollection 2023 Mar.
2
Lipocrinology - the relationship between lipids and endocrine function.
Drugs Context. 2018 Jan 31;7:212514. doi: 10.7573/dic.212514. eCollection 2018.
本文引用的文献
1
Carbimazole-induced agranulocytosis.
J Pharmacol Pharmacother. 2015 Oct-Dec;6(4):228-30. doi: 10.4103/0976-500X.171881.
2
Role of Cholestyramine in Refractory Hyperthyroidism: A Case Report and Literature Review.
Am J Case Rep. 2015 Jul 24;16:486-90. doi: 10.12659/AJCR.893821.
3
Cholestyramine for thyrotoxicosis?
J Fam Pract. 2013 Apr;62(4):E1-2.
4
Low doses of cholestyramine in the treatment of hyperthyroidism.
Endocrine. 2008 Aug-Dec;34(1-3):52-5. doi: 10.1007/s12020-008-9107-5. Epub 2008 Oct 23.
5
The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Clin Endocrinol (Oxf). 2005 May;62(5):521-4. doi: 10.1111/j.1365-2265.2005.02249.x.
6
Light symptoms following a high-dose intentional L-thyroxine ingestion treated with cholestyramine.
Horm Res. 2002;57(1-2):61-3. doi: 10.1159/000057950.
Zotero 插件